Research Progress on Structure and Anti-Gynecological Malignant Tumor of Shikonin
- PMID: 35873044
- PMCID: PMC9304652
- DOI: 10.3389/fchem.2022.935894
Research Progress on Structure and Anti-Gynecological Malignant Tumor of Shikonin
Abstract
Gynecological malignancy seriously threatens the physical and mental health of women. Shikonin is a naphthoquinone compound with a variety of biological activities. Studies have shown that shikonin can inhibit cell proliferation, promote cell apoptosis and induce cell necrosis. And in recent years, shikonin are also being increasingly used for the study of gynecological malignant diseases. Therefore, we reviewed the mechanism of action and structure optimization of shikonin in gynecological malignant tumors, in order to provide some reference for further research and development of related drug.
Keywords: anti-cancer; gynecological malignancy; review; shikonin; structural modification.
Copyright © 2022 Ke, Kong, Xu, Chen, Dong, Li, Zeng and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Chen X. Y. (2009). Effect of Shikonin on Reversal of Drug Resistance and Expression of MRP and LRP in JAR/MTX Cells of Choriocarcinoma. Changchun: Jilin University. [D].
-
- Commission (2020). Pharmacopoeia of People’s Republic of China:One Edition. Beijing: China Medical Science Press, 355–356. [M].
-
- Du C. S., Wang S., Zhang F., Yu M. X., Song X. K., Wang C. (2018). Inhibitory Effect of Alkannin Combined with Cisplatin on Hela Cells of Cervical Carcinoma and its Mechanism. J. Shenyang Pharm. Univ. 35 (3), 232–237. [J]. 10.14066/j.cnki.cn21-1349/r.2018.03.012 - DOI
Publication types
LinkOut - more resources
Full Text Sources
